Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CAO Ryan M. Bartolucci sold 339 shares of the stock in a transaction on Monday, December 16th. The stock was sold at an average price of $40.23, for a total value of $13,637.97. Following the sale, the chief accounting officer now directly owns 71,007 shares of the company's stock, valued at approximately $2,856,611.61. This represents a 0.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Tempus AI Stock Down 12.0 %
NASDAQ:TEM opened at $34.29 on Thursday. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The stock's fifty day moving average price is $52.24.
Analyst Upgrades and Downgrades
TEM has been the topic of several analyst reports. Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a "buy" rating and a $74.00 target price on the stock. Loop Capital boosted their target price on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research report on Tuesday, October 15th. Stifel Nicolaus cut Tempus AI from a "buy" rating to a "hold" rating and raised their price target for the company from $45.00 to $65.00 in a report on Monday, November 11th. Piper Sandler restated a "neutral" rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Finally, Wolfe Research started coverage on Tempus AI in a research report on Friday, December 13th. They issued an "outperform" rating and a $60.00 price objective for the company. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $56.00.
AI breakthrough about to upend industry
From Porter & Company | Ad
Everyone is talking about AI right now.
The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI.
But here’s the thing.
I urge you to watch it now.
Get Our Latest Research Report on TEM
Hedge Funds Weigh In On Tempus AI
Hedge funds have recently added to or reduced their stakes in the business. Kovitz Investment Group Partners LLC purchased a new stake in shares of Tempus AI in the third quarter valued at about $1,367,000. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the last quarter. Captrust Financial Advisors purchased a new stake in Tempus AI in the 3rd quarter valued at approximately $2,726,000. Sigma Planning Corp acquired a new stake in Tempus AI during the 3rd quarter valued at $1,323,000. Finally, Dakota Wealth Management purchased a new position in Tempus AI during the third quarter worth $1,185,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
